{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:18:37Z","timestamp":1759011517123,"version":"3.44.0"},"reference-count":22,"publisher":"BMJ","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"published-print":{"date-parts":[[1983,7]]},"abstract":"<jats:p>A new nephelometric technique to measure C3d as an indicator of complement activation, is described. C3d is isolated at high concentration of polyethyleneglycol (PEG), incubated with commercially available anti-C3d antiserum at a final concentration of 2.5% PEG and then measured in a Behring Laser Nephelometer. In contrast to previously available techniques our assay detects the low concentrations of C3d present in all normal subjects, which result from the continuous C3 catabolism occurring in vivo. We have also measured C3d blood concentrations in a large number of patients with diseases associated with complement activation. Raised C3d concentrations were found in 68% of rheumatoid arthritis, 57% of primary biliary cirrhosis, 38% of chronic active hepatitis, 100% of Gram-negative bacteraemia and 100% of malaria. The nephelometric technique has proved to be sensitive, economical and fast, and could be adapted for routine determination of C3d blood concentrations to monitor disease activity and response to treatment.<\/jats:p>","DOI":"10.1136\/jcp.36.7.793","type":"journal-article","created":{"date-parts":[[2007,6,9]],"date-time":"2007-06-09T00:50:46Z","timestamp":1181350246000},"page":"793-797","source":"Crossref","is-referenced-by-count":39,"title":["Clinical application of a new nephelometric technique to measure complement activation."],"prefix":"10.1136","volume":"36","author":[{"given":"D","family":"Vergani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Bevis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B A","family":"Nasaruddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Mieli-Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D E","family":"Tee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1983,7,1]]},"reference":[{"key":"ref_1","first-page":"18","article-title":"Complement","volume-title":"Clinical aspects of immunology","author":"Lachmann, P.J.; Peters, D.K.","year":"1982","unstructured":"Lachmann PJ, Peters DK. Complement. In: Lachmann PJ, Peters DK, eds. Clinical aspects of immunology. Oxford: Blackwell Scientific Publications, 1982:18-49."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1056\/NEJM197209282871306","article-title":"The complement system of man. (Fourth of four parts.)","volume":"287","author":"Ruddy, S.; Gigli, I.; Austen, K.F.","year":"1972","unstructured":"Ruddy S, Gigli I, Austen KF. The complement system of man. (Fourth of four parts.) N Engl J Med 1972;287:642-6.","journal-title":"N Engl J Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/clinchem\/24.1.7","article-title":"The value of complement assays in clinical chemistry","volume":"24","author":"Whicher, J.T.","year":"1978","unstructured":"Whicher JT. The value of complement assays in clinical chemistry. Clin Chem 1978;24:7-22.","journal-title":"Clin Chem"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev.bi.44.070175.003405","volume":"44","author":"Muller-Eberhard, H.J.","year":"1975","unstructured":"Muller-Eberhard HJ. Complement. Adv Rev Biochem 1975;44:697-723.","journal-title":"Complement. Adv Rev Biochem"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60042-5","article-title":"Molecular biology and chemistry of the alternative pathway of complement","volume":"29","author":"Muller-Eberhard, H.J.; Schreiber, R.D.","year":"1980","unstructured":"Muller-Eberhard HJ, Schreiber RD. Molecular biology and chemistry of the alternative pathway of complement. Adv Immunol 1980;29:1-53.","journal-title":"Adv Immunol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1056\/NEJM198007313030505","article-title":"Current concepts in immunology-The alternative pathway of complement. A system for host resistance to microbial infection","volume":"303","author":"Fearon, D.I.; Austen, K.F.","year":"1980","unstructured":"Fearon DI, Austen KF. Current concepts in immunology-The alternative pathway of complement. A system for host resistance to microbial infection. N Engl J Med 1980;303:259-63.","journal-title":"N Engl J Med"},{"key":"ref_7","first-page":"650","article-title":"Antigenic determinants of human (3 Ic-and,8 1 G-Globulins","volume":"96","author":"CD, I.West; NC, Davis; J, Forristal J.Herbst; R, Spitzer","year":"1966","unstructured":"I West CD, Davis NC, Forristal J. Herbst J, Spitzer R. Antigenic determinants of human (3 Ic-and,8 1 G-Globulins. J Immunol 1966;96:650-8.","journal-title":"J Immunol"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/000456327301000134","article-title":"Automated two-dimensional immunoelectrophoresis and its application to the analysis of C3 and C4 in rheumatoid arthritis and systemic lupus erythematosus (SLE)","volume":"10","author":"Versey, J.M.B.","year":"1973","unstructured":"Versey JMB. Automated two-dimensional immunoelectrophoresis and its application to the analysis of C3 and C4 in rheumatoid arthritis and systemic lupus erythematosus (SLE). Ann Clin Biochem 1973;10:100-6.","journal-title":"Ann Clin Biochem"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(76)90148-4","article-title":"Detection of complement activation by counter immunoelectrophoresis (CIE)","volume":"13","author":"Arroyave, C.M.; Tan, E.M.","year":"1976","unstructured":"Arroyave CM, Tan EM. Detection of complement activation by counter immunoelectrophoresis (CIE). J Immunol Methods 1976;13: 101-12.","journal-title":"J Immunol Methods"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/jcp.33.8.781","article-title":"Clinical applications of immunofixation: detection and quatitation of complement activation","volume":"33","author":"Whicher, J.T.; Higginson, J.; Riches, P.G.; Radford, S.","year":"1980","unstructured":"Whicher JT, Higginson J, Riches PG, Radford S. Clinical applications of immunofixation: detection and quatitation of complement activation. J Clin Pathol 1980;33:781-5.","journal-title":"J Clin Pathol"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI108065","article-title":"Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis","volume":"56","author":"Perrin, L.H.; Lambert, P.H.; Miescher, P.A.","year":"1975","unstructured":"Perrin LH, Lambert PH, Miescher PA. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. J Clin Invest 1975;56:165-76.","journal-title":"J Clin Invest"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1172\/JCI107708","article-title":"Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia","volume":"53","author":"Charlesworth, J.A.; Gwyn Williams, D.; Sherington, E.; Lachmann, P.J.; Peters, D.K.","year":"1974","unstructured":"Charlesworth JA, Gwyn Williams D, Sherington E, Lachmann PJ, Peters DK. Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest 1974;53:1578-87.","journal-title":"J Clin Invest"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1084\/jem.156.1.205","article-title":"Breakdown of C3 after complement activation. Identification of a new fragment, C3g, using monoclonal antibodies","volume":"156","author":"Lachmann, P.J.; Pangburn, M.K.; Oldroyd, R.G.","year":"1982","unstructured":"Lachmann PJ, Pangburn MK, Oldroyd RG. Breakdown of C3 after complement activation. Identification of a new fragment, C3g, using monoclonal antibodies. J Exp Med 1982;156: 205-16.","journal-title":"J Exp Med"},{"key":"ref_14","first-page":"747","article-title":"Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. Clin Exp Immunol","volume":"48","author":"Mallya, R.K.; Vergani, D.; Tee, D.E.H.","year":"1982","unstructured":"Mallya RK, Vergani D, Tee DEH, et al. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity. Clin Exp Immunol 1982;48:747-53."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00000441-195108000-00009","article-title":"Serum complement in rheumatoid arthritis","volume":"222","author":"Vaughan, J.H.; Bayles, T.B.; Favor, C.V.","year":"1951","unstructured":"Vaughan JH, Bayles TB, Favor CV. Serum complement in rheumatoid arthritis. Am J Med Sci 1951;222:186-92.","journal-title":"Am J Med Sci"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0065-2776(08)60299-0","article-title":"The immunopathology of joint inflammation in rheumatoid arthritis","volume":"16","author":"Zvaifter, N.J.","year":"1972","unstructured":"Zvaifter NJ. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Imnmunol 1972;16:265-336.","journal-title":"Adv Imnmunol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0016-5085(19)33249-4","article-title":"Significance of serum complement levels in chronic liver disease","volume":"63","year":"1972","unstructured":"Significance of serum complement levels in chronic liver disease. Gastroenterology 1972;63:653-9.","journal-title":"Gastroenterology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM197802022980502","article-title":"Circulating immune complexes and complement activation in primary biliary cirrhosis","volume":"298","author":"Wands, JR, Dienstag; JL, Bhan; AK, Feller; ER, Isselbacher; K.J.","year":"1978","unstructured":"Wands JR, Dienstag JL, Bhan AK, Feller ER, Isselbacher KJ. Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med 1978;298:233-7.","journal-title":"N Engl J Med"},{"key":"ref_19","first-page":"548","article-title":"Complement activation in chronic liver disease","volume":"47","author":"Munoz, L.E.; De Villiers, D.; Markham, D.; Whaley, K.; Thomas, H.C.","year":"1982","unstructured":"Munoz LE, De Villiers D, Markham D, Whaley K, Thomas HC. Complement activation in chronic liver disease. Clin Exp Immunol 1982;47:548-54.","journal-title":"Clin Exp Immunol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM197301042880105","article-title":"Serum complement levels in bacteremia due to gram-negative organisms","volume":"288","author":"McCabe, W.R.","year":"1973","unstructured":"McCabe WR. Serum complement levels in bacteremia due to gram-negative organisms. N Engl J Med 1973;288:21-3.","journal-title":"N Engl J Med"},{"key":"ref_21","first-page":"362","article-title":"Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS)","volume":"118","author":"Morrison, D.C.; Kline, L.F.","year":"1977","unstructured":"Morrison DC, Kline LF. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol 1977;118:362-8.","journal-title":"J Immunol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/oxfordjournals.bmb.a071752","article-title":"Immunity to malaria","volume":"38","author":"Playfair, J.H.L.","year":"1982","unstructured":"Playfair JHL. Immunity to malaria. Br Med Bull 1982;38:153-9.","journal-title":"Br Med Bull"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp.36.7.793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:57:23Z","timestamp":1758819443000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp.36.7.793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,7]]},"references-count":22,"journal-issue":{"issue":"7","published-online":{"date-parts":[[1983,7,1]]},"published-print":{"date-parts":[[1983,7]]}},"alternative-id":["10.1136\/jcp.36.7.793"],"URL":"https:\/\/doi.org\/10.1136\/jcp.36.7.793","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"type":"print","value":"0021-9746"},{"type":"electronic","value":"1472-4146"}],"subject":[],"published":{"date-parts":[[1983,7]]}}}